Amendment to Schedule 13D for Amneal Pharmaceuticals, Inc.

This Amendment No. 4 to Schedule 13D, filed by Chintu Patel, updates the ownership and transaction details related to Class A Common Stock of Amneal Pharmaceuticals, Inc. The amendment reports that on October 3, 2025, a trust controlled by Patel contributed 13,257,287 shares of Class A Common Stock to Shivkan Holdings X, LLC, a Delaware limited liability company. Additionally, Shivkan entered into a Margin Loan Agreement with Citibank, N.A., pledging the same shares as collateral. The amendment also provides updated ownership details, indicating that Patel beneficially owns 25,910,032 shares, representing 8.2% of the outstanding Class A Common Stock. The filing includes exhibits such as the Pledge and Security Agreement and the Issuer Letter Agreement.